Ravi Kumar Jairam
Ravi Kumar Jairam publishes mostly in Organic Chemistry, Molecular Biology and Oncology, on topics such as Protein purification and stability, Quinazolinone synthesis and applications and COVID-19 Clinical Research Studies.
- World rank
- #6,940,217 of 7,710,434 ranked researchers
- Rank in India
- #238,788 of 280,097
- Works
- 22
- Citations
- 212
- Citations per work
- 9.6
What does Ravi Kumar Jairam research?
Ravi Kumar Jairam's work is mostly in Medicine (34%), Chemistry (15%), Biochemistry, Genetics and Molecular Biology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else837.1%
- Health Sciences734.0%
- Medicine734.0%
- Physical Sciences315.3%
- Chemistry315.3%
- Life Sciences313.6%
- 1Organic Chemistry15% of their works
- 2Molecular Biology14% of their works
- 3Oncology14% of their works
- 4Ophthalmology8% of their works
- 5Infectious Diseases7% of their works
- 6Radiology, Nuclear Medicine and Imaging5% of their works
Research topics
- Protein purification and stability
- Quinazolinone synthesis and applications
- COVID-19 Clinical Research Studies
- Cancer Immunotherapy and Biomarkers
- COVID-19 and healthcare impacts
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Reactions of Organic Compounds
Which keywords describe Ravi Kumar Jairam's research?
The keywords of their largest research topics: Synthesis, Pandemic, Anticancer, Antimicrobial, Heterocycles, Biopharmaceuticals, Cancer and Clinical Characteristics.
- Oxazolones
- Imidazoles
- Drug Discovery
- Quinazoline
- PD-1 and PD-L1
- Immune Checkpoint Blockade
- Cancer
- Biopharmaceuticals
- Antimicrobial
- Pandemic
- Synthesis
- Anticancer
- Heterocycles
- COVID-19
- Clinical Characteristics
- Indirubin
- Protein Aggregation
- SARS-CoV-2
- Heterocyclic Compounds
- Medicinal Chemistry
- Triazines
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Synthesis73 topics
- Pandemic62 topics
- Anticancer52 topics
- Antimicrobial52 topics
- Heterocycles42 topics
- Biopharmaceuticals31 topic
- COVID-1931 topic
- Cancer31 topic
- Clinical Characteristics31 topic
- Immune Checkpoint Blockade31 topic
- Indirubin31 topic
- PD-1 and PD-L131 topic
- Protein Aggregation31 topic
- Quinazoline31 topic
- SARS-CoV-231 topic
- Drug Discovery21 topic
- Heterocyclic Compounds21 topic
- Imidazoles21 topic
- Medicinal Chemistry21 topic
- Oxazolones21 topic
- Triazines21 topic
Where does Ravi Kumar Jairam work?
Ravi Kumar Jairam's main affiliation in the publication record is Jubilant Life Sciences (India), India.
How many publications and citations does Ravi Kumar Jairam have?
OpenAlex counts 22 works and 212 citations for Ravi Kumar Jairam, an h-index of 9, ranking #6,940,217 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ravi Kumar Jairam. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.